These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 1362800

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Identification of gp108, a pathogenic antigen of passive Heymann nephritis, as dipeptidyl peptidase IV.
    Natori Y, Hayakawa I, Shibata S.
    Clin Exp Immunol; 1987 Nov; 70(2):434-9. PubMed ID: 2892601
    [Abstract] [Full Text] [Related]

  • 6. Loss of antigens associated with the apical endocytotic pathway in proximal tubules from rats with heymann nephritis.
    Gutmann EJ, Niles JL, McCluskey RT, Brown D.
    Am J Pathol; 1991 May; 138(5):1243-55. PubMed ID: 1708948
    [Abstract] [Full Text] [Related]

  • 7. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
    Makker SP, Tramontano A.
    J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Involvement of an antigen distinct from the Heymann antigen in membranous glomerulonephritis in the mouse.
    Assmann KJ, Ronco P, Tangelder MM, Lange WP, Verroust P, Koene RA.
    Lab Invest; 1989 Jan; 60(1):138-46. PubMed ID: 2642986
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A major pathogenic antigen of Heymann nephritis is present exclusively in the renal proximal tubule brush border--studies with a monoclonal antibody against pronase-digested tubular antigen.
    Tsukada Y, Ono K, Maezawa A, Yano S, Naruse T.
    Clin Exp Immunol; 1994 May; 96(2):303-10. PubMed ID: 8187338
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synergistic effects of anti-gp330 and anti-dipeptidyl peptidase type IV antibodies in the induction of glomerular damage.
    van Leer EH, de Roo GM, Bruijn JA, Hoedemaeker PJ, de Heer E.
    Exp Nephrol; 1993 May; 1(5):292-300. PubMed ID: 7915960
    [Abstract] [Full Text] [Related]

  • 15. Studies of experimental membranous nephropathy.
    Couser WG, Salant DJ, Adler S, Madaio MP.
    Transplant Proc; 1982 Sep; 14(3):474-81. PubMed ID: 6217598
    [No Abstract] [Full Text] [Related]

  • 16. Megalin/GP330 and pathogenetic concepts of membranous glomerulopathy (MGN).
    Kerjaschki D.
    Kidney Blood Press Res; 2000 Sep; 23(3-5):163-6. PubMed ID: 11031710
    [No Abstract] [Full Text] [Related]

  • 17. Membranous nephropathy. Insights from Heymann nephritis.
    Cavallo T.
    Am J Pathol; 1994 Apr; 144(4):651-8. PubMed ID: 8160766
    [No Abstract] [Full Text] [Related]

  • 18. Epitope specificity of anti-gp330 autoantibodies determines the development of proteinuria in active Heymann nephritis.
    Van Leer EH, Ronco P, Verroust P, van der Wal AM, Hoedemaeker PJ, De Heer E.
    Am J Pathol; 1993 Mar; 142(3):821-9. PubMed ID: 7681258
    [Abstract] [Full Text] [Related]

  • 19. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
    Camussi G, Brentjens JR, Noble B, Kerjaschki D, Malavasi F, Roholt OA, Farquhar MG, Andres G.
    J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.